Shots:
- The US FDA has granted 510 (k) clearance to HealthMammo for boosting early detection of breast cancer in mammograms
- The tool utilizes the AI to prioritize and identify suspicious mammograms and is automatically sent to Zebra’s platform, where it gets processed and analyzed for suspected breast lesions. The HealthMammo product then returns its result to the radiologist
- Zebra Medical’s HealthMammo may help radiologists deal with the screening management strategy of the post COVID backlog and triaging. The tool is the first solution for oncology to receive FDA clearance, as part of the company’s AI1 “All-In-One” bundle
Click here to read full press release/ article | Ref: Business wire | Image: Business wire
